Physician profile
Regis William Haid
NPI 1811992449
$25,494,720.82
in general payments reported to CMS, 2019-2025
15 companies · $3.2M in 2025
The $3.2M reported for 2025 was more than what 99% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3.6M · 2020: $3.8M · 2021: $3.6M · 2022: $3.8M · 2023: $3.7M · 2024: $3.9M · 2025: $3.2M.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $9.1M · Consulting Fee: $1.5M · Travel and Lodging: $23K · Food and Beverage: $12K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $9,138,421.96 |
| Consulting Fee | $1,510,262.01 |
| Travel and Lodging | $22,572.92 |
| Food and Beverage | $11,830.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nuvasive, INC. | $13,681,015.10 | 2019-2023 | Reline, Base, Brigade |
| Medtronic, INC. | $4,732,151.39 | 2021-2025 | Atlantis Anterior Cervical Plate System, Trimline Instrument Set, Venture Anterior Cervical Plate System |
| Globus Medical, INC. | $4,543,473.08 | 2019-2025 | Reline, Precept, Versatie |
| Medtronic USA, INC. | $2,536,606.00 | 2019-2020 | |
| Mml US, INC. | $877.61 | 2022-2023 | Reactiv8 |
| Stryker Corporation | $134.60 | 2019 | |
| Medical Device Business Services, INC. | $124.35 | 2021 | |
| Alphatec Spine, INC | $94.82 | 2024 | Battalion Tlif - Pc |
| Depuy Synthes Sales INC. | $78.97 | 2019-2021 | |
| Radius Health, INC. | $73.37 | 2019-2021 | |
| Integra Lifesciences Corporation | $27.64 | 2019 | |
| Zimmer Biomet Holdings, INC. | $23.74 | 2019 | |
| Carlsmed, INC. | $22.78 | 2021 | |
| Misonix INC | $17.37 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$4,742,182.82 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Regis Haid listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.